Ultragenyx Pharmaceutical Inc.

Insider Reports History

Location
Novato, CA
Signature
/s/ Mardi C. Dier, EVP and Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ultragenyx Pharmaceutical Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. Director Common Stock 1,400,000 $26,208,420 $18.72 11 Aug 2021 Direct

Insider Reports Filed by Ultragenyx Pharmaceutical Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARCT Arcturus Therapeutics Holdings Inc. 10 Aug 2021 2 -$43,631,250 4 Director 12 Aug 2021, 17:11